Neuroprotective Effects of IV Glutathione Several studies have explored the neuroprotective properties of IV glutathione administration
Targets Stubborn Visceral Fat Stacks including Tesamorelin and Ipamorelin are clinically designed to target stubborn visceral fat and abdominal fat directly, while actively preserving lean muscle mass, tracked through DEXA body composition scans
These medications include semaglutide, liraglutide, and dulaglutide
That approach ignores medical history, mental health, reproductive goals, and the very real fact that these medications affect appetite, digestion, and nutrition status
GLP-1 drug shows little benefit for people with Parkinsons disease 5 February 2025 The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinsons disease, finds a new study led by UCL researchers
Further zooming into the impacts of GLP-1 on food consumption, a Morgan Stanley Research report provides interesting early insights on how GLP-1 users eating habits are changing (see figure below)